NCT04107922

Nutraceutical on Hyperglycemia

Metabolic Actions of a Supplement of Ilex Paraguariensis, White Mulberry and Chromium Picolinate in Non-diabetic Subjects With Dysglycemia, a Randomized Clinical Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 148 (actual)
• Sponsor: University of Pavia · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The aim will be to evaluate if Glicoset® 1000, a nutraceutical containing Ilex Paraguariensis, White Mulberry and Chromium Picolinate, can be effective in improving glycemic status in subject with dysglycemia.

Detailed description

The aim will be to evaluate if Glicoset® 1000, a nutraceutical containing Ilex Paraguariensis, White Mulberry and Chromium Picolinate, can be effective in improving glycemic status in subject with dysglycemia. The investigators will enroll patients with impaired fasting plasma glucose (IFG) or impaired glucose tolerance (IGT), not taking hypoglycemic agents (both pharmaceuticals or nutraceutical agents). Patients will be randomized to take placebo or Glicoset® 1000 for 3 months, in a randomized, double-blind, placebo-controlled design. Glicoset® 1000 and placebo will be self-administered once a day, 1 tablet during the breakfast.

Conditions

• Dysglycemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Glicoset	Patients will take a nutraceutical containing Ilex Paraguariensis, White Mulberry and Chromium Picolinate
OTHER	Placebo	Patients will take placebo

Timeline

• Start date: 2018-10-01
• Primary completion: 2019-08-31
• Completion: 2019-08-31
• First posted: 2019-09-27
• Last updated: 2019-10-01

Locations

1 site across 1 country: Italy